Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterNo recent work listed

Natalya Beglyarova

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5088962283. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

  1. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Co-author DOI 10.18632/oncotarget.12642↗
  2. Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-0149↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Egor Bobrov · 2 shared papers, 2016–2017 · strength 0.11
  2. Igor A. Astsaturov · 2 shared papers, 2016–2017 · strength 0.11
  3. Erica A. Golemis · 2 shared papers, 2016–2017 · strength 0.11
  4. Diana Behrens · 1 shared paper, 2016 · strength 0.04
  5. John Parker Hoffman · 1 shared paper, 2016 · strength 0.04
  6. Louis M. Weiner · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.